Cart
sales@molnova.com
BAY-091
CAS No. 2922280-34-8
BAY-091( —— )
Catalog No. M35342 CAS No. 2922280-34-8
BAY-091 is a novel, potent, and highly selective inhibitor of PIP4K2A kinase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 188 | In Stock |
|
| 5MG | 178 | In Stock |
|
| 10MG | 283 | In Stock |
|
| 25MG | 451 | In Stock |
|
| 50MG | 631 | In Stock |
|
| 100MG | 848 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBAY-091
-
NoteResearch use only, not for human use.
-
Brief DescriptionBAY-091 is a novel, potent, and highly selective inhibitor of PIP4K2A kinase.
-
DescriptionBAY-091 is a novel potent and highly selective inhibitor of the kinase PIP4K2A.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2922280-34-8
-
Formula Weight440.47
-
Molecular FormulaC26H21FN4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (283.79 mM; Ultrasonic )
-
SMILESN([C@@H](C(O)=O)CC)C=1C2=C(N=C(C1C#N)C3=CC=C(C=C3)C4=C(F)C(C)=CC=C4)C=NC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wortmann L, et al. Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A. J Med Chem. 2021 Nov 11;64(21):15883-15911.?
molnova catalog
related products
-
RuPhos
RuPhos is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
-
5,6-DIAMINOPYRIDINE-...
5,6-DIAMINOPYRIDINE-3-CARBOXYLIC ACID METHYL ESTER is a useful organic compound for research related to life sciences. The catalog number is T9829 and the CAS number is 104685-76-9.
-
GRGDSP TFA
GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor which can be used to modify the surface of cardiovascular implants such as vascular grafts to promote endothelialization.
